• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Protein

  2026-04-29

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye optimized for efficient, water-soluble labeling of amino groups in proteins and peptides. Its sulfonated structure reduces quenching and enhances compatibility with low-solubility targets. APExBIO’s A8107 reagent is validated for reproducible protein conjugation in advanced fluorescence and cell biology protocols.

• Temozolomide: Advanced Workflows for DNA Repair Mechanism Re

  2026-04-28

  Temozolomide, a small-molecule alkylating agent, empowers researchers to induce precise DNA lesions and unravel DNA repair and chemotherapy resistance mechanisms in high-grade glioma and beyond. This guide provides actionable workflow enhancements, troubleshooting insights, and experimental best practices that maximize the scientific value of APExBIO’s research-grade Temozolomide.

• Guanabenz Acetate: Optimizing α2-Adrenergic Receptor Assays

  2026-04-28

  Guanabenz Acetate enables researchers to dissect α2-adrenergic receptor signaling with unmatched selectivity, driving breakthroughs in GPCR pathway modulation and antiviral immunity. Its robust solubility profile and high analytical purity make it the preferred choice for advanced neuroscience and stress granule research.

• PSA-CD56/Siglec-7 Axis Drives Immune Evasion in ccRCC

  2026-04-27

  This study identifies polysialylated CD56 (PSA-CD56) as a novel glyco-immune checkpoint in clear cell renal cell carcinoma (ccRCC), directly mediating immune evasion by suppressing CD8+ T cell function via Siglec-7 engagement. Disrupting this axis restores T cell activity and apoptosis of tumor cells, revealing a promising therapeutic target and new perspectives for overcoming immunotherapy resistance.

• Optimizing Workflows with the 10 mM dNTP Mixture: Protocols

  2026-04-27

  Unleash the full potential of your PCR and DNA synthesis workflows using the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. Discover advanced troubleshooting strategies and protocol enhancements that set this molecular biology reagent apart in applications from nucleic acid delivery to high-fidelity sequencing.

• Sisomicin vs. Tobramycin: In Vitro Activity Against Clinical

  2026-04-26

  This article examines the in vitro comparative activity of sisomicin, a novel aminoglycoside antibiotic, against over 560 clinical bacterial isolates, emphasizing its relative potency and resistance patterns compared to established agents such as tobramycin and gentamicin. The findings provide actionable insights for researchers studying antibiotic efficacy and resistance mechanisms in Gram-negative pathogens.

• Berberrubine Chloride: Translational Leverage in Anti-Hyperu

  2026-04-25

  Explore the multifaceted utility of Berberrubine chloride, a 9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride, as a research-grade agent with distinct anti-hyperuricemia and anti-cancer pathway modulation. This article uniquely bridges mechanistic insights and protocol guidance, grounded in pivotal recent studies.

• Axitinib (AG 013736): Mechanisms and Strategic Impact in Tra

  2026-04-24

  Gain advanced insight into how Axitinib (AG 013736) empowers translational researchers to dissect, optimize, and translate antiangiogenic strategies for cancer therapy. This article bridges mechanistic depth with actionable guidance, contextualizes in vitro findings, and positions Axitinib as a uniquely potent VEGFR inhibitor in the evolving landscape of cancer biology research.

• QPRT Drives Breast Cancer Invasiveness via PLC-Linked Pathwa

  2026-04-24

  Liu et al. (2021) uncover how upregulation of quinolinate phosphoribosyltransferase (QPRT) promotes invasiveness in breast cancer through myosin light chain phosphorylation, implicating PLC signaling as a key mediator. Their integrative use of genetic and pharmacological inhibitors, including the PLC inhibitor U-73122, provides new mechanistic insight into cancer cell migration and highlights QPRT as a potential therapeutic target.

• Jiedu Xiaozheng Yin Induces M1 Macrophage Polarization in CA

  2026-04-23

  This study demonstrates that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine formula, inhibits the progression of colitis-associated colorectal cancer (CAC) by promoting macrophage polarization towards the pro-inflammatory M1 phenotype through TLR4 signaling. The findings highlight the therapeutic potential of immune modulation in CAC and provide mechanistic insight relevant for future translational research.

• CP-673451 in Precision Oncology: Advanced PDGFR Inhibition I

  2026-04-23

  Explore how CP-673451, a selective PDGFRα/β inhibitor, is transforming cancer research through highly specific signaling pathway analysis and advanced tumor model applications. This article delivers a unique, evidence-driven perspective on optimizing experimental design with CP-673451.

• Ziprasidone Hydrochloride (HCl): Mechanism and Research Evid

  2026-04-22

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic with dual activity as a serotonin/dopamine receptor antagonist and a validated inhibitor of GOT1. It demonstrates antitumor efficacy in preclinical pancreatic cancer models and is supplied by APExBIO as SKU A5350 for research applications. This article details its mechanism, evidential benchmarks, and protocol integration for neuroscience and oncology research.

• Bay 11-7821 (BAY 11-7082): Reliable IKK Inhibition for Cell

  2026-04-22

  This scenario-driven article helps biomedical researchers and lab technicians address common challenges in cell viability, apoptosis, and inflammatory pathway assays using Bay 11-7821 (BAY 11-7082), SKU A4210. Drawing on validated protocols, published data, and real-world use cases, we demonstrate how this selective IKK inhibitor delivers reproducible results for sensitive cancer and inflammation research workflows.

• Senescence Gene Signature Predicts Prognosis in Cholangiocar

  2026-04-21

  This study establishes a machine learning-derived gene signature based on cellular senescence pathways to robustly predict prognosis and therapy response in cholangiocarcinoma. The findings advance the use of integrative bioinformatics for risk stratification and highlight potential functional biomarkers for clinical research.

• Kif9 Motor Controls Centriolar Satellite Positioning in Inte

  2026-04-21

  Vicente et al. (2025) demonstrate that the kinesin motor Kif9 is essential for regulating the spatial distribution of centriolar satellites around the centrosome during interphase. Their work shows that loss of Kif9 leads to pericentrosomal satellite clustering, altered proteostasis, and subsequent defects in centrosome maturation and mitosis, highlighting the importance of Kif9-mediated satellite positioning for genomic stability.

406 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page